NCT06305728 - Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

March 4, 2030

Study Completion Date

March 4, 2030

Conditions

Pancreatic Cyst

Interventions

DIAGNOSTIC_TEST

89Zr-DFO-HuMab-5B1 immunoPET

Participants who choose to will undergo immunoPET before surgery.

DIAGNOSTIC_TEST

HP MRI

Participants who choose to will undergo HP MRI before surgery.

COMBINATION_PRODUCT

Blood assay

Will be drawn within 6 weeks of surgery and annually as post operative care

Trial Locations (8)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All protocol activites), New York

NOT_YET_RECRUITING

Weill Cornell Medical Center (Specimen Analysis Only), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre

11725

RECRUITING

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack

07920

RECRUITING

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER